Seeking Alpha

CGIX
  Cancer Genetics, Inc. - NASDAQ

10/30/2014, 8:58 AM ET
  • Chris Bunge | Send Message 13 Feb

    $CGIX partnership w. Roche=HUGE! They will have exclusive rights to test lung cancer patients to see if they qualify for ROCHE drug Tarceva.
    Reply
      CGIX vs. ETF Alternatives
      Company Description
      Cancer Genetics, Inc., is an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis and response to treatment of cancer.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States